fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2023

Journal of contemporary brachytherapy

Faivre JC

Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.

2023

BMC cancer

Pivot X

Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting.

2023

Pediatric blood & cancer

Raze T

PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.

2023

Cellular & molecular immunology

Viot J

CD8 CD226 T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery.

2023

Radiation oncology (London, England)

Kuntz L

Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.

2023

Breast cancer (Tokyo, Japan)

Kada Mohammed S

HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study.

2023

Cancer medicine

Atsou KM

Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.

2023

International journal of pharmaceutics

Freis B

Bioconjugation studies of an EGF-R targeting ligand on dendronized iron oxide nanoparticles to target head and neck cancer cells.

2023

Cancers

Thouvenin J

Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients' Outcomes?

2023

Frontiers in immunology

Lopes S

Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis.